Protein boost tested to save lives in deadly Post-Surgery shock
NCT ID NCT07212582
Summary
This study aims to see if adding a natural blood protein called albumin to standard intensive care improves survival for patients with surgical septic shock. About 304 adult patients in a surgical ICU will be randomly assigned to receive either standard care alone or standard care plus albumin infusions for up to 3 days. The main goal is to see if this approach helps more patients survive the first 28 days after their critical illness begins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, Bangkoknoi, 10700, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.